MENU
DAWN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Day One Biopharmaceuticals (DAWN) Ownership - Who owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
759.02M
P/E Ratio
N/A
Total Cash
453.1M
Projected Growth
N/A
Total Debt
3M
Revenue
187.64M
Risk (Beta)
0.15
Dividend Yield
N/A
Total Cash/Share
4.42
Total Debt/Equity
N/A
Revenue/Share
1.85 USD as % of share price
Fundamentals
DAWN
Capitalization
759M
P/E Ratio
N/A
Risk (Beta)
0.15
Dividend Yield
N/A
Total Cash
453M
Total Cash/Share
4.42
Total Debt
3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.85%
Revenue
188M
ROE
N/A
Book Value
461M
P/B Ratio
1.65
Cash Flow
N/A
Earnings
-0.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
9.65
Current Revenue Per Employee
187337.02
Dividends Per Share - Security
N/A
EBITDA
-108.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.90
Revenue To Assets
-20.66
Shares Held By Institutions
965M
Shares Outstanding - Current
102M
Total Liabilities
58.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-40.963
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DAWN showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com